UnknownPHASE1, PHASE2NCT04214821
The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%
Studying Endophthalmitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National University of Malaysia
- Principal Investigator
- Wan Haslina Wan Abdul Halim, M.DDepartment of Ophthalmology, UKM Medical Centre
- Intervention
- Levofloxacin Ophthalmic Solution(drug)
- Enrollment
- 128 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2022
Study locations (2)
- UKM Medical Centre, Cheras, Kuala Lumpur, Malaysia
- Faculty of Pharmacy, National University of Malaysia, Kuala Lumpur, Kuala Lumpur, Malaysia
Collaborators
Santen Pharmaceutical Co., Ltd.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04214821 on ClinicalTrials.govOther trials for Endophthalmitis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT07176130Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in SingaporeSingapore National Eye Centre
- RECRUITINGNCT07175311Vascular Changes Associated With Endophthalmitis.Asociación para Evitar la Ceguera en México
- RECRUITINGNCT05432336Complex Ocular Infection, Optimization of Microbiological DiagnosisAssistance Publique - Hôpitaux de Paris
- RECRUITINGNCT05372861Nanopore Sequencing in OphthalmologyMedical University of Graz